Pharmacy Benefit Manager Express Scripts Inc. Enraged, Looks To Force Gilead Sciences, Inc. To Cut Price Of Sovaldi

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Express Scripts (ESRX) plans to ask its clients, which include employers, health insurance plans and government agencies, to join a group that would stop using Gilead’s (GILD) Sovaldi treatment for Hepatitis C once the FDA has approved rival drugs.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC